Cost-Benefit Analysis of Haemophilus influenzae Type b Vaccination in Children in Spain (Q59783231)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10345159%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

title

Cost-benefit analysis of Haemophilus influenzae type b vaccination in children in Spain (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10345159%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

main subject

cost–benefit analysis

1 reference

inferred from title

Haemophilus influenzae

object named as

Haemophilus influenzae

1 reference

inferred from title

author

Pilar Guallar-Castillón

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10345159%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

author name string

F J Jiménez

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10345159%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

C Rubio Terrés

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10345159%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

E Guallar

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10345159%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

publication date

1 January 1999

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10345159%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10345159%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

volume

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10345159%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10345159%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

page(s)

75-83

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10345159%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.2165/00019053-199915010-00005

8 December 2019

exact match

0 references

cites work

Cost of treatment and prevention of Haemophilus influenzae type b disease. An international perspective

1 reference

12 December 2020

Decline of Childhood Haemophilus influenzae Type b (Hib) Disease in the Hib Vaccine Era

1 reference

12 December 2020

Prevention of Hemophilus influenzae type b bacteremic infections with the capsular polysaccharide vaccine

1 reference

12 December 2020

Cost benefit analysis of Haemophilus influenzae type b vaccination programme in Israel

1 reference

12 December 2020

[Invasive Haemophilus influenzae type B infections in infancy (1981-1990)]

1 reference

12 December 2020

Haemophilus influenzae vaccines for infants in Spain

1 reference

12 December 2020

Haemophilus influenzae type b capsular polysaccharide vaccine in children: a double-blind field study of 100,000 vaccinees 3 months to 5 years of age in Finland

1 reference

12 December 2020

[Resistance in Haemophilus influenzae in Spain. 2d study (1990)]

1 reference

12 December 2020

Effectiveness and safety of an Haemophilus influenzae type b conjugate vaccine (PRP-T) in young infants. Kaiser-UCLA Vaccine Study Group.

1 reference

12 December 2020

Cost-benefit analysis of two strategies for prevention of Haemophilus influenzae type b infection

1 reference

12 December 2020

Efficacy in infancy of oligosaccharide conjugate Haemophilus influenzae type b (HbOC) vaccine in a United States population of 61,080 children. The Northern California Kaiser Permanente Vaccine Study Center Pediatrics Group.

1 reference

12 December 2020

Cost effectiveness of vaccination against pneumococcal pneumonia

1 reference

12 December 2020

Efficacy and safety of a Haemophilus influenzae type b capsular polysaccharide-tetanus protein conjugate vaccine

1 reference

12 December 2020

Anonymous testing of newborn infants for HIV antibodies as a basis for estimating prevalence of HIV in childbearing women: the 1991-1994 study in Spain

1 reference

12 December 2020

Cost-benefit analysis for the use of Haemophilus influenzae type b conjugate vaccine in Santiago, Chile.

1 reference

12 December 2020

Haemophilus influenzae type b septic arthritis in children: report of 23 cases

1 reference

12 December 2020

Comparison of the epidemiology and cost of Haemophilus influenzae type b disease in five western countries

1 reference

12 December 2020

Invasive disease by Haemophilus influenzae type b: current state of prevention by vaccination

1 reference

12 December 2020

Guidelines for economic analysis of pharmaceutical products: a draft document for Ontario and Canada

1 reference

12 December 2020

Cost-benefit analysis of general vaccination against Haemophilus influenzae type b in Sweden.

1 reference

12 December 2020

Immunization of US children with Hemophilus influenzae type b polysaccharide vaccine. A cost-effectiveness model of strategy assessment

1 reference

12 December 2020

[Cost-effectiveness analysis of different alternatives of universal vaccination against hepatitis B in the region of Murcia]

1 reference

12 December 2020

Progress toward elimination of Haemophilus influenzae type b disease among infants and children--United States, 1993-1994.

1 reference

12 December 2020

Safety and immunogenicity of oligosaccharide conjugate Haemophilus influenzae type b (HbOC) vaccine in infancy. The Northern California Kaiser Permanente Vaccine Study Center Pediatrics Group

1 reference

12 December 2020

Carriage of Haemophilus influenzae type b in children after widespread vaccination with conjugate Haemophilus influenzae type b vaccines

1 reference

12 December 2020

Economic evaluation of general childhood vaccination against Haemophilus influenzae type b in Sweden.

1 reference

12 December 2020

[Review of the data on incidence of invasive disease and meningitis caused by Haemophilus influenzae in children under 5 years of age in Spain]

1 reference

12 December 2020

Cost-benefit analysis of Haemophilus influenzae type b prevention: conjugate vaccination at eighteen months of age.

1 reference

12 December 2020

The epidemiology and prevention of disease caused by Haemophilus influenzae type b.

1 reference

12 December 2020